Buy Cellectar BioSciences Stock | CLRB Stock Price & Latest News | Public
CLRB

Cellectar BioSciences

$0.00 (0.00%)Today
    Small Market Cap

    About CLRB

    Cellectar BioSciences, Inc. engages in the development of phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. Its portfolio includes CLR 131, which seeks to treat relapse or refractory multiple myeloma; CLR 125, which intends to treat micro meta...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.14
    -0.28
    -0.42
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$0.20

    Actual EPS
    Q3 2020

    Stats

    Market Cap$31,68M
    Volume2,71k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$3.33
    1 Year Low$1.01
    Open$1.18
    High$1.21
    Low$1.18

    Buy any stock with any amount of money.

    Download the App
    Download the app